Answer:
Hyaline Membrane Disease
Explanation:
Hyaline Membrane Disease or the respiratory distress syndrome is a disease caused in newborn babies especially in premature infants due to the absence of the biological surfactant.
A glassy membrane composed of the dead cells and the protein is formed and lines the tiny sacs called alveoli which decreases the volume of the alveoli and difficulty in the exchange of gases in the infants.
Thus, Hyaline Membrane Disease is the correct answer.
I'm not completely sure but I came up with Carbon dioxide, methane, water vapor, and nitrous oxide. I hope this is right and maybe helps you. Good luck!!
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
